Trinity Biotech PLC expected to post earnings of 7 cents a share - Earnings Preview

Trinity Biotech

07/09/2021 12:07

* Trinity Biotech PLC  TRIB.OQ   TRIB.O  is expected to show a
rise in quarterly revenue when it reports results on September
9. 
* The Bray, Wicklow-based company is expected to report   a
49.8% increase in revenue to $24 million from $16.02 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Trinity Biotech PLC is
for earnings of 7 cents per share. 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Trinity Biotech
PLC is $7​, about 62.4% above​ its last closing price
of $2.63. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021              0.07       0.10      Beat    44.3
 Dec. 31 2020              0.14       0.36      Beat    157.1
 Sep. 30 2020  10.00       0.10       0.32      Beat    220​
 ​​            ​                                        ​
 Dec. 31 2019              0.06       0.09      Beat    50​
 Sep. 30 2019  0.06        0.06       0.04      Missed  -28.3
 Jun. 30 2019              0.07       0.00      Missed  -97.1
 This summary was machine generated September 7 at 11:07 GMT. 
All figures in US dollars unless otherwise stated